Oxytocin reduces adipose tissue inflammation in obese mice

Abstract Background Obesity and adipose tissue expansion is characterized by a chronic state of systemic inflammation that contributes to disease. The neuropeptide, oxytocin, working through its receptor has been shown to attenuate inflammation in sepsis, wound healing, and cardiovascular disease. T...

Full description

Bibliographic Details
Main Authors: Angela Szeto, Monia Cecati, Raisa Ahmed, Philip M. McCabe, Armando J. Mendez
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-020-01364-x
_version_ 1819202625087733760
author Angela Szeto
Monia Cecati
Raisa Ahmed
Philip M. McCabe
Armando J. Mendez
author_facet Angela Szeto
Monia Cecati
Raisa Ahmed
Philip M. McCabe
Armando J. Mendez
author_sort Angela Szeto
collection DOAJ
description Abstract Background Obesity and adipose tissue expansion is characterized by a chronic state of systemic inflammation that contributes to disease. The neuropeptide, oxytocin, working through its receptor has been shown to attenuate inflammation in sepsis, wound healing, and cardiovascular disease. The current study examined the effects of chronic oxytocin infusions on adipose tissue inflammation in a murine model of obesity, the leptin receptor-deficient (db/db) mouse. Methods The effect of obesity on oxytocin receptor protein and mRNA expression in adipose tissue was evaluated by Western blotting and real-time polymerase chain reaction. Mice were implanted with osmotic minipumps filled with oxytocin or vehicle for 8 weeks. At study endpoint adipose tissue inflammation was assessed by measurement of cytokine and adipokine mRNA tissue levels, adipocyte size and macrophage infiltration via histopathology, and plasma levels of adiponectin and serum amyloid A as markers of systemic inflammation. Results The expression of adipose tissue oxytocin receptor was increased in obese db/db mice compared to lean controls. In adipose tissue oxytocin infusion reduced adipocyte size, macrophage infiltration, IL-6 and TNFα mRNA expression, and increased the expression of the anti-inflammatory adipokine, adiponectin. In plasma, oxytocin infusion reduced the level of serum amyloid A, a marker of systemic inflammation, and increased circulating adiponectin. Conclusions In an animal model of obesity and diabetes chronic oxytocin treatment led to a reduction in visceral adipose tissue inflammation and plasma markers of systemic inflammation, which may play a role in disease progression.
first_indexed 2024-12-23T04:06:59Z
format Article
id doaj.art-e12d6bd5f4b443c08af6251b24507d80
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-12-23T04:06:59Z
publishDate 2020-08-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-e12d6bd5f4b443c08af6251b24507d802022-12-21T18:00:36ZengBMCLipids in Health and Disease1476-511X2020-08-0119111110.1186/s12944-020-01364-xOxytocin reduces adipose tissue inflammation in obese miceAngela Szeto0Monia Cecati1Raisa Ahmed2Philip M. McCabe3Armando J. Mendez4Department of Psychology, University of MiamiDepartment of Medicine and Diabetes Research Institute, University of Miami Miller School of MedicineDepartment of Psychology, University of MiamiDepartment of Psychology, University of MiamiDepartment of Medicine and Diabetes Research Institute, University of Miami Miller School of MedicineAbstract Background Obesity and adipose tissue expansion is characterized by a chronic state of systemic inflammation that contributes to disease. The neuropeptide, oxytocin, working through its receptor has been shown to attenuate inflammation in sepsis, wound healing, and cardiovascular disease. The current study examined the effects of chronic oxytocin infusions on adipose tissue inflammation in a murine model of obesity, the leptin receptor-deficient (db/db) mouse. Methods The effect of obesity on oxytocin receptor protein and mRNA expression in adipose tissue was evaluated by Western blotting and real-time polymerase chain reaction. Mice were implanted with osmotic minipumps filled with oxytocin or vehicle for 8 weeks. At study endpoint adipose tissue inflammation was assessed by measurement of cytokine and adipokine mRNA tissue levels, adipocyte size and macrophage infiltration via histopathology, and plasma levels of adiponectin and serum amyloid A as markers of systemic inflammation. Results The expression of adipose tissue oxytocin receptor was increased in obese db/db mice compared to lean controls. In adipose tissue oxytocin infusion reduced adipocyte size, macrophage infiltration, IL-6 and TNFα mRNA expression, and increased the expression of the anti-inflammatory adipokine, adiponectin. In plasma, oxytocin infusion reduced the level of serum amyloid A, a marker of systemic inflammation, and increased circulating adiponectin. Conclusions In an animal model of obesity and diabetes chronic oxytocin treatment led to a reduction in visceral adipose tissue inflammation and plasma markers of systemic inflammation, which may play a role in disease progression.http://link.springer.com/article/10.1186/s12944-020-01364-xAdipose tissueAnti-inflammationObesityOxytocinObese mouse model
spellingShingle Angela Szeto
Monia Cecati
Raisa Ahmed
Philip M. McCabe
Armando J. Mendez
Oxytocin reduces adipose tissue inflammation in obese mice
Lipids in Health and Disease
Adipose tissue
Anti-inflammation
Obesity
Oxytocin
Obese mouse model
title Oxytocin reduces adipose tissue inflammation in obese mice
title_full Oxytocin reduces adipose tissue inflammation in obese mice
title_fullStr Oxytocin reduces adipose tissue inflammation in obese mice
title_full_unstemmed Oxytocin reduces adipose tissue inflammation in obese mice
title_short Oxytocin reduces adipose tissue inflammation in obese mice
title_sort oxytocin reduces adipose tissue inflammation in obese mice
topic Adipose tissue
Anti-inflammation
Obesity
Oxytocin
Obese mouse model
url http://link.springer.com/article/10.1186/s12944-020-01364-x
work_keys_str_mv AT angelaszeto oxytocinreducesadiposetissueinflammationinobesemice
AT moniacecati oxytocinreducesadiposetissueinflammationinobesemice
AT raisaahmed oxytocinreducesadiposetissueinflammationinobesemice
AT philipmmccabe oxytocinreducesadiposetissueinflammationinobesemice
AT armandojmendez oxytocinreducesadiposetissueinflammationinobesemice